Director, Government Pricing & Contracting Analytics

About us

The Menarini Group is present in 70 countries and our products are sold in 140 locations worldwide. With around 18,000 employees, the Group produces over 500 million packs of drugs annually across 18 manufacturing sites, including a biotech plant for monoclonal antibodies. Menarini has a strong commitment to oncology, with a pipeline of five investigational compounds for hematological and solid tumors. The acquisition of Stemline Therapeutics in 2020 strengthened Menarini’s oncology portfolio, adding commercial and clinical-stage assets such as Tagraxofusp, the first approved treatment for blastic plasmacytoid dendritic cell neoplasm (BPDCN) in the U.S. and EU. Menarini also commercializes Selinexor in Europe and other regions for hematologic cancers and solid tumors, and Elacestrant, an oral SERD approved for hormone receptor-positive advanced breast cancer.

Responsibilities

• Oversee all government pricing calculations, analyses, and submissions, including Average Selling Price (ASP), Average Manufacturer’s Price (AMP), Best Price (BP), Public Health Service (PHS)/340B pricing, Non-Federal Average Manufacturer’s Price (Non-FAMP), Federal Ceiling Price (FCP), and Federal Supply Schedule prices (FSS) in accordance with the Medicaid Drug Rebate Program and Federal Program Guidelines.
• Partner with key stakeholders to ensure timely and accurate filing of all government reporting to avoid significant monetary penalties for late or inaccurate submissions.
• Represent Market Access on cross-functional teams to evaluate issues impacting government pricing and prepare analyses to understand the impact of new pricing and contracting strategies on Government Pricing calculations.
• Ensure compliance with laws governing government programs, including Medicaid, within written policies, procedures, and standards of conduct.
• Maintain an understanding of the marketplace and changes that may impact government price reporting and government channel strategy.
• Responsible for maintenance of documentation and procedures regarding government pricing, as well as internal and external audits.
• Inform brand forecasts including account and channel-level gross-to-net projections, Medicaid Unit forecasts, and government impact of proposed strategy changes (CPI penalties, Medicaid Mandated Rebate, BP).
• Manage the bottoms-up model for in-line and launch products, including forecasting brand gross-to-net deductions.
• Provide GPO contracting support, including pre- and post-deal analyses.
• Participate in analyses to understand the impact of market events on government price reporting and development of channel strategies (e.g., assessment of pipeline products coverage, analysis of impact of payer coverage policies, and provider/channel economics).
• Proactively seek and recommend enhancements and improvements in Market Access processes, including recommending resources, new approaches, negotiating agreeable solutions, or involving next-level management as needed.
• Shape and monitor the evolution of the market access and government policy landscape in the short, near, and long-term.

Requirements

• Bachelor’s degree; preferably in a relevant field (Marketing, Science, Economics, Finance, or related).
• 5 years of related healthcare business experience in the pharmaceutical industry.
• In-depth understanding of Government Pricing, Market Access, and Healthcare delivery.
• Analytical skills including problem-solving, forecasting, contract development, and financial modeling.
• Demonstrated negotiation and relationship-building skills.
• Ability to manage multiple priorities.
• Strong oral and written communication skills, with a focus on customer service.

Pay

Base Salary Range of $213,000–$258,000.

Benefits

• Short- and Long-Term Incentive Programs.
• Fidelity 401(k) with a 6% company match.
• Anthem Premier PPO and HDHP insurance plans.
• Company-paid Basic Life & AD&D insurance.
• Pre-tax FSA/HSA programs.